The Glomerular Disease Therapeutics market was valued at USD 12,590.40 Million in 2021 and is expected to reach USD 18,601.70 Million by 2029, growing at a CAGR of 5% (2022-2029). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.